Rebus Financial Statements From 2010 to 2025
| RBSH Stock | USD 0.0001 0.00 0.00% |
Check Rebus Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rebus Holdings' main balance sheet or income statement drivers, such as , as well as many indicators such as . Rebus financial statements analysis is a perfect complement when working with Rebus Holdings Valuation or Volatility modules.
Rebus |
Rebus Holdings Company Return On Asset Analysis
Rebus Holdings' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Rebus Holdings Return On Asset | -1.13 |
Most of Rebus Holdings' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rebus Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Rebus Holdings has a Return On Asset of -1.1304. This is 87.08% lower than that of the Healthcare sector and 95.21% lower than that of the Biotechnology industry. The return on asset for all United States stocks is notably higher than that of the company.
Rebus Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Rebus Holdings's current stock value. Our valuation model uses many indicators to compare Rebus Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rebus Holdings competition to find correlations between indicators driving Rebus Holdings's intrinsic value. More Info.Rebus Holdings is currently regarded as top stock in return on asset category among its peers. It also is currently regarded number one company in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Rebus Holdings by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Rebus Holdings' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Rebus Holdings Financial Statements
Investors use fundamental indicators, such as Rebus Holdings' revenue or net income, to determine how well the company is positioned to perform in the future. Although Rebus Holdings' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. The company was founded in 2003 and is based in Westlake Village, California. Rebus Hldgs operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Rebus Pink Sheet
Rebus Holdings financial ratios help investors to determine whether Rebus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rebus with respect to the benefits of owning Rebus Holdings security.